AU7335396A - Membrane-fusible liposome with the use of recombinant sendai virus - Google Patents

Membrane-fusible liposome with the use of recombinant sendai virus

Info

Publication number
AU7335396A
AU7335396A AU73353/96A AU7335396A AU7335396A AU 7335396 A AU7335396 A AU 7335396A AU 73353/96 A AU73353/96 A AU 73353/96A AU 7335396 A AU7335396 A AU 7335396A AU 7335396 A AU7335396 A AU 7335396A
Authority
AU
Australia
Prior art keywords
membrane
sendai virus
recombinant sendai
fusible
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73353/96A
Other languages
English (en)
Inventor
Mamoru Hasegawa
Atsushi Kato
Yoshiyuki Magai
Fukashi Murai
Yosuke Suzuki
Katsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dnavec Research Inc
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Publication of AU7335396A publication Critical patent/AU7335396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU73353/96A 1995-11-01 1996-10-22 Membrane-fusible liposome with the use of recombinant sendai virus Abandoned AU7335396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30825295 1995-11-01
JP7-308252 1995-11-01
PCT/JP1996/003070 WO1997016171A1 (fr) 1995-11-01 1996-10-22 Liposome a membrane fusible faisant appel a un virus sendai recombinant

Publications (1)

Publication Number Publication Date
AU7335396A true AU7335396A (en) 1997-05-22

Family

ID=17978777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73353/96A Abandoned AU7335396A (en) 1995-11-01 1996-10-22 Membrane-fusible liposome with the use of recombinant sendai virus

Country Status (3)

Country Link
JP (1) JP3992200B2 (ja)
AU (1) AU7335396A (ja)
WO (1) WO1997016171A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE399206T1 (de) * 1999-05-18 2008-07-15 Dnavec Research Inc Ribonukleoproteinkomplex aus paramyxovirus
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
KR20070058607A (ko) * 1999-05-18 2007-06-08 가부시키가이샤 디나벡크 겐큐쇼 엔벨로프 유전자 결손 파라믹소과 바이러스 벡터
JP4838962B2 (ja) * 1999-11-02 2011-12-14 株式会社ディナベック研究所 気道上皮細胞への外因性遺伝子導入用組換えセンダイウイルスベクター
EP1504766A4 (en) * 2002-04-30 2006-11-02 Dnavec Research Inc MEDICAMENT OR GENE SUPPORT COMPOSITION WITH HEMAGGLUTININ ACTIVITY
ES2561060T3 (es) 2005-10-28 2016-02-24 Id Pharma Co., Ltd. Transferencia génica en citoblastos epiteliales de las vías respiratorias mediante el uso de vectores de lentivíricos pseudotipados con una proteína espina de virus de ARN
ES2613808T3 (es) 2011-07-29 2017-05-26 Oncotherapy Science, Inc. Péptido derivado de ERAP1 y uso del mismo
JPWO2020111167A1 (ja) 2018-11-30 2021-10-28 国立大学法人徳島大学 Ｂｉｇ３−ｐｈｂ２相互作用阻害ｐｈｂ２由来ペプチドを含む乳がん治療薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses

Also Published As

Publication number Publication date
JP3992200B2 (ja) 2007-10-17
WO1997016171A1 (fr) 1997-05-09

Similar Documents

Publication Publication Date Title
AU9397098A (en) Methods and cell line useful for production of recombinant adeno-associated viruses
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
AU5801296A (en) Crosslinkable polypeptide compositions
AU4273097A (en) Headband with dual material construction
AU6255096A (en) Pegylated modified proteins
AU5827896A (en) Inhaler with collapsible chamber
AU2705395A (en) Fas associated proteins
AU9222698A (en) Novel molecules of the tnfr-ligand-related protein family and uses thereof
AU4689596A (en) Anti-inflammatory cd14 peptides
AU5320296A (en) Modified viral envelope polypeptide
AU6299594A (en) Recombinant fowlpox virus s-fpv-043 and uses thereof
AU1099597A (en) Novel xylanases and uses thereof
AU7335396A (en) Membrane-fusible liposome with the use of recombinant sendai virus
AUPO026596A0 (en) Viral peptide
AU2131195A (en) Prophenins - antibiotic peptides
AU1991799A (en) Molecules associated with the human suppressor of fused gene
AU5652396A (en) Glucose-inducible recombinant viral vector
AU3288497A (en) Mammalian tolloid-like gene and protein
AU6715094A (en) Recombinant vaccine
AU5550296A (en) Conotoxin peptides
AU5293198A (en) Promoter of the human endoglin gene and its use
AU2168795A (en) Recombinant Gibberellin DNA and uses thereof
AUPM489194A0 (en) Peptides
AU1954995A (en) Viral replicon
AU6087694A (en) The l-plastin promoter region and its uses